HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Inman Selected Research

Necrosis

2/2004TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Inman Research Topics

Disease

3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020 - 05/2009
3Asthma (Bronchial Asthma)
10/2014 - 05/2006
3Inflammation (Inflammations)
06/2010 - 02/2008
2Hypoglycemia (Reactive Hypoglycemia)
03/2022 - 01/2020
2Respiratory Hypersensitivity
06/2010 - 01/2010
1Hyperglycemia
03/2022
1Neoplasms (Cancer)
01/2020
1Pain (Aches)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Arthritis (Polyarthritis)
01/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Cancer Pain
01/2020
1Idiopathic Pulmonary Fibrosis
01/2020
1Hyperinsulinism (Hyperinsulinemia)
01/2018
1Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
01/2018
1Allergic Rhinitis
10/2014
1Hypothalamic hamartomas
01/2013
1Hypothyroidism
01/2013
1Obesity
01/2013
1Precocious Puberty
01/2013
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2013
1Slipped Capital Femoral Epiphyses
01/2013
1Vascular Remodeling
05/2009
1Pulmonary Hypertension
05/2009
1Fibrosis (Cirrhosis)
05/2009
1Eosinophilia
02/2008
1Bacterial Infections (Bacterial Infection)
02/2004
1Granuloma
02/2004
1Respiratory Insufficiency (Respiratory Failure)
02/2004
1Infections
02/2004
1Necrosis
02/2004

Drug/Important Bio-Agent (IBA)

2Glucose (Dextrose)FDA LinkGeneric
03/2022 - 01/2020
2Growth Hormone (Somatotropin)IBA
01/2018 - 01/2013
2OvalbuminIBA
10/2014 - 01/2010
1Diphosphonates (Bisphosphonates)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1ChemokinesIBA
01/2020
1Analgesics (Analgesic Drugs)IBA
01/2020
1CytokinesIBA
01/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
1Insulin (Novolin)FDA Link
01/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016
1ProgesteroneFDA LinkGeneric
10/2014
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2013
1Hormones (Hormone)IBA
01/2013
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2013
1ProstaglandinsIBA
06/2010
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2010
1AerosolsIBA
01/2010
1AntigensIBA
01/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2009
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2008
1ciclesonideFDA Link
05/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2004

Therapy/Procedure

4Therapeutics
01/2020 - 02/2008
1Perioperative Care
01/2018
1Duration of Therapy
05/2006